- Home
- Publications
- Publication Search
- Publication Details
Title
Engineering CAR-T cells to activate small-molecule drugs in situ
Authors
Keywords
-
Journal
Nature Chemical Biology
Volume 18, Issue 2, Pages 216-225
Publisher
Springer Science and Business Media LLC
Online
2021-12-31
DOI
10.1038/s41589-021-00932-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejection
- (2021) Leila Peraro et al. MOLECULAR THERAPY
- Targeted Cellular Micropharmacies: Cells Engineered for Localized Drug Delivery
- (2020) Thomas J. Gardner et al. Cancers
- Advances in chimeric antigen receptor T cells
- (2020) Ofrat Beyar-Katz et al. CURRENT OPINION IN HEMATOLOGY
- CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response
- (2019) Nicholas F. Kuhn et al. CANCER CELL
- CAR T‐cell therapy: Full speed ahead
- (2019) David Sermer et al. HEMATOLOGICAL ONCOLOGY
- Antibody–Drug Conjugates for Cancer Treatment
- (2018) John M. Lambert et al. Annual Review of Medicine
- T cell senescence and CAR-T cell exhaustion in hematological malignancies
- (2018) Dimitri Kasakovski et al. Journal of Hematology & Oncology
- Driving T-cell immunotherapy to solid tumors
- (2018) Ken Garber NATURE BIOTECHNOLOGY
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Gene therapy comes of age
- (2018) Cynthia E. Dunbar et al. SCIENCE
- Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System
- (2018) Mauro P. Avanzi et al. Cell Reports
- Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
- (2018) Sarwish Rafiq et al. NATURE BIOTECHNOLOGY
- Tumor Antigen Escape from CAR T-cell Therapy
- (2018) Robbie G. Majzner et al. Cancer Discovery
- Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management
- (2018) Jennifer N. Brudno et al. BLOOD REVIEWS
- Therapeutic T cell engineering
- (2017) Michel Sadelain et al. NATURE
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
- (2017) Sattva S. Neelapu et al. Nature Reviews Clinical Oncology
- Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells
- (2016) Michael Boice et al. CELL
- Translating antibody directed enzyme prodrug therapy (ADEPT) and prospects for combination
- (2016) Surinder K. Sharma et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Ultrasmall dual-modality silica nanoparticle drug conjugates: Design, synthesis, and characterization
- (2015) Barney Yoo et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Adoptive Cell Therapy—Tumor-Infiltrating Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors
- (2015) Steven A. Feldman et al. SEMINARS IN ONCOLOGY
- Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
- (2015) E. Sotillo et al. Cancer Discovery
- Improved vectors and genome-wide libraries for CRISPR screening
- (2014) Neville E Sanjana et al. NATURE METHODS
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Broader View: Microbial Enzymes and Their Relevance in Industries, Medicine, and Beyond
- (2013) Neelam Gurung et al. Biomed Research International
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase
- (2009) Elmer B Santos et al. NATURE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now